Live Breaking News & Updates on உலகளாவிய ஆரோக்கியம் ப்ரோக்ராம்
Stay updated with breaking news from உலகளாவிய ஆரோக்கியம் ப்ரோக்ராம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
'We are a petri dish': world watches UK's race between vaccine and virus | Coronavirus theguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theguardian.com Daily Mail and Mail on Sunday newspapers.
Healthcare Is A Corruption Hotspot In The European Union, New Report Shows forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.
BusinessWorld May 25, 2021 | 8:18 pm PHILIPPINE STAR/ MICHAEL VARCAS THREE more coronavirus vaccine developers applied for clinical trials in the Philippines, the Department of Science and Technology said on Tuesday. In a press briefing, Science and Technology Undersecretary Rowena Cristina L. Guevara said the task group on vaccine evaluation and selection received clinical trial applications from West China Hospital and Sichuan University, Shenzhen Kangtai Biological Products Co., and Eubiologics Co. Ltd. “Evaluation of the first two new applications are ongoing, while Eubiologics Co. Ltd. are still completing some requirements,” she told an online briefing. The applications are for phase III clinical trials, she said. ....
The World Health Organisation has given authorisation for emergency use of a Covid-19 vaccine manufactured by China’s Sinopharm, potentially paving the way for millions of doses to reach needy countries through a UN-backed programme. The decision by a WHO technical advisory group opens the possibility that the Sinopharm vaccine could be included in the UN-backed Covax programme in coming weeks or months, and distributed through Unicef and the WHO’s regional office in the Americas. Sinopharm has released little data publicly, aside from efficacy numbers for its two jabs – one developed by the Beijing Institute of Biological Products and the other by the Wuhan Institute of Biological Products. ....
Sinopharm jab will also be added to Covax programme for the developing world in the coming weeks The WHO is recommending the vaccine for adults 18 years and older, in a two-dose schedule with a spacing of three to four weeks. Photograph: Robert Atanasovski/AFP/Getty Images The WHO is recommending the vaccine for adults 18 years and older, in a two-dose schedule with a spacing of three to four weeks. Photograph: Robert Atanasovski/AFP/Getty Images Fri 7 May 2021 14.26 EDT Last modified on Fri 7 May 2021 15.00 EDT The World Health Organization has given emergency use approval to one of the Chinese-made Sinopharm’s Covid-19 vaccines in a major boost to the product’s credibility. ....